In 2017 the total diagnosed prevalent population of Hereditary Angioedema in 7MM was 14,435. In France the prevalent cases of Hereditary Angioedema was found to be 1,346, while the UK and Spain had 1,301 and 537 prevalent cases in 2017.
In 2017, the Hereditary Angioedema Market Size was USD 1,741.75 million in seven major markets, which is expected to increase during the forecast period 2017-2030.
Some of the key players in the Hereditary Angioedema Market includes BioCryst Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, and many others.
For more detailed information on Hereditary Angioedema Market, visit: https://www.delveinsight.com/report-store/hereditary-angioedema-market